Apogee Therapeutics, Inc. APGE Accounts Payable
Accounts Payable at other companies
Other financials
Where this comes from
Reported directly by Apogee Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AccountsPayableCurrent.
The official record: Apogee Therapeutics, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Apogee Therapeutics, Inc.'s accounts payable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Apogee Therapeutics, Inc.'s accounts payable?
- Apogee Therapeutics, Inc. (APGE) reported accounts payable of $1.24M in Q1 2026.
- How has Apogee Therapeutics, Inc.'s accounts payable changed year-over-year?
- Apogee Therapeutics, Inc.'s accounts payable decreased by 49.4% year-over-year, from $2.45M to $1.24M.
- What is the long-term trend for Apogee Therapeutics, Inc.'s accounts payable?
- Over 2 years (2023 to 2025), Apogee Therapeutics, Inc.'s accounts payable has grown at a -19.4% compound annual growth rate (CAGR), from $14.98M to $9.72M.
- What does accounts payable mean?
- Amounts owed to suppliers and vendors for goods and services received but not yet paid. A primary source of short-term trade financing.